LYEL
Lyell Immunopharma Inc.
Company Overview
| Mkt Cap | $321.02M | Price | $16.66 |
| Volume | 11.07K | Change | +0.79% |
| P/E Ratio | -0.9 | Open | $16.33 |
| Revenue | $61.0K | Prev Close | $16.53 |
| Net Income | $-343.0M | 52W Range | $7.65 - $30.00 |
| Div Yield | N/A | Target | $11.00 |
| Overall | 58 | Value | 60 |
| Quality | 55 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyLyell Immunopharma Inc. (LYEL) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $16.66 with a market capitalization of $321.02 million. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows LYEL with a volume of 11K shares. The stock opened down 1.21% from yesterday's close of $16.53. Current analyst estimates project earnings of $-11.91 per share for this year, with next year targeting $-12.68.
LYEL demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for LYEL include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -34.0%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:44 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LYEL | $16.66 | +0.8% | 11.07K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |